Revenue (Tables)

6 Months Ended

Jun. 28, 2024

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and six-month periods ended June 28, 2024 and June 30, 2023 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.

	Biotechnology		Life Sciences		Diagnostics		Total
For the Three-Month Period Ended June 28, 2024:
Geographical region:
North America(a)	$	607	$	785	$	1,042	$	2,434
Western Europe	567		374		380		1,321
Other developed markets(b)	81		116		95		292
High-growth markets(c)	458		495		743		1,696
Total	$	1,713	$	1,770	$	2,260	$	5,743
Revenue type:
Recurring	$	1,478	$	1,208	$	2,003	$	4,689
Nonrecurring	235		562		257		1,054
Total	$	1,713	$	1,770	$	2,260	$	5,743
For the Three-Month Period Ended June 30, 2023:
Geographical region:
North America(a)	$	611	$	757	$	982	$	2,350
Western Europe	684		375		365		1,424
Other developed markets(b)	72		124		100		296
High-growth markets(c)	518		540		784		1,842
Total	$	1,885	$	1,796	$	2,231	$	5,912
Revenue type:
Recurring	$	1,534	$	1,104	$	1,958	$	4,596
Nonrecurring	351		692		273		1,316
Total	$	1,885	$	1,796	$	2,231	$	5,912

	Biotechnology		Life Sciences		Diagnostics		Total
For the Six-Month Period Ended June 28, 2024:
Geographical region:
North America(a)	$	1,121	$	1,566	$	2,379	$	5,066
Western Europe	1,113		746		786		2,645
Other developed markets(b)	160		241		194		595
High-growth markets(c)	843		962		1,428		3,233
Total	$	3,237	$	3,515	$	4,787	$	11,539
Revenue type:
Recurring	$	2,787	$	2,400	$	4,297	$	9,484
Nonrecurring	450		1,115		490		2,055
Total	$	3,237	$	3,515	$	4,787	$	11,539
For the Six-Month Period Ended June 30, 2023:
Geographical region:
North America(a)	$	1,229	$	1,465	$	2,106	$	4,800
Western Europe	1,331		739		785		2,855
Other developed markets(b)	151		252		217		620
High-growth markets(c)	1,038		1,049		1,499		3,586
Total	$	3,749	$	3,505	$	4,607	$	11,861
Revenue type:
Recurring	$	3,045	$	2,143	$	4,070	$	9,258
Nonrecurring	704		1,362		537		2,603
Total	$	3,749	$	3,505	$	4,607	$	11,861

(a) The Company defines North America as the United States and Canada.

(b) The Company defines other developed markets as all the markets of the world that are not North America, Western Europe or high-growth markets.

(c) The Company defines high-growth markets as developing markets of the world experiencing accelerated growth, over extended periods, in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high-growth markets.